Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 65

1.

Ptpn11 Deletion in CD4+ Cells Does Not Affect T Cell Development and Functions but Causes Cartilage Tumors in a T Cell-Independent Manner.

Miah SMS, Jayasuriya CT, Salter AI, Reilly EC, Fugere C, Yang W, Chen Q, Brossay L.

Front Immunol. 2017 Oct 16;8:1326. doi: 10.3389/fimmu.2017.01326. eCollection 2017.

2.

Lacrimal Gland NK Cells Are Developmentally and Functionally Similar to Conventional NK Cells.

Erick T, Grigoryan L, Brossay L.

Immunohorizons. 2017 Apr 1;1(2):2-9. doi: 10.4049/immunohorizons.1700008.

3.

NFIL3 Expression Distinguishes Tissue-Resident NK Cells and Conventional NK-like Cells in the Mouse Submandibular Glands.

Erick TK, Anderson CK, Reilly EC, Wands JR, Brossay L.

J Immunol. 2016 Sep 15;197(6):2485-91. doi: 10.4049/jimmunol.1601099. Epub 2016 Aug 12.

4.

The role of MHC class Ib-restricted T cells during infection.

Anderson CK, Brossay L.

Immunogenetics. 2016 Aug;68(8):677-91. doi: 10.1007/s00251-016-0932-z. Epub 2016 Jul 1. Review.

5.

Phenotype and functions of conventional and non-conventional NK cells.

Erick TK, Brossay L.

Curr Opin Immunol. 2016 Feb;38:67-74. doi: 10.1016/j.coi.2015.11.007. Epub 2015 Dec 17. Review.

6.

Role of SHIP1 in Invariant NKT Cell Development and Functions.

Anderson CK, Salter AI, Toussaint LE, Reilly EC, Fugère C, Srivastava N, Kerr WG, Brossay L.

J Immunol. 2015 Sep 1;195(5):2149-2156. doi: 10.4049/jimmunol.1500567. Epub 2015 Jul 31.

7.

Role of type I interferon receptor signaling on NK cell development and functions.

Guan J, Miah SM, Wilson ZS, Erick TK, Banh C, Brossay L.

PLoS One. 2014 Oct 21;9(10):e111302. doi: 10.1371/journal.pone.0111302. eCollection 2014.

8.

Mouse natural killer cell development and maturation are differentially regulated by SHIP-1.

Banh C, Miah SM, Kerr WG, Brossay L.

Blood. 2012 Nov 29;120(23):4583-90. doi: 10.1182/blood-2012-04-425009. Epub 2012 Oct 3.

9.

Activated iNKT cells promote memory CD8+ T cell differentiation during viral infection.

Reilly EC, Thompson EA, Aspeslagh S, Wands JR, Elewaut D, Brossay L.

PLoS One. 2012;7(5):e37991. doi: 10.1371/journal.pone.0037991. Epub 2012 May 23.

10.

Targeting natural killer cells and natural killer T cells in cancer.

Vivier E, Ugolini S, Blaise D, Chabannon C, Brossay L.

Nat Rev Immunol. 2012 Mar 22;12(4):239-52. doi: 10.1038/nri3174. Review.

11.

Chromosome y regulates survival following murine coxsackievirus b3 infection.

Case LK, Toussaint L, Moussawi M, Roberts B, Saligrama N, Brossay L, Huber SA, Teuscher C.

G3 (Bethesda). 2012 Jan;2(1):115-21. doi: 10.1534/g3.111.001610. Epub 2012 Jan 1.

12.

Comparing the kinetics of NK cells, CD4, and CD8 T cells in murine cytomegalovirus infection.

Schlub TE, Sun JC, Walton SM, Robbins SH, Pinto AK, Munks MW, Hill AB, Brossay L, Oxenius A, Davenport MP.

J Immunol. 2011 Aug 1;187(3):1385-92. doi: 10.4049/jimmunol.1100416. Epub 2011 Jun 22.

13.

Salivary gland NK cells are phenotypically and functionally unique.

Tessmer MS, Reilly EC, Brossay L.

PLoS Pathog. 2011 Jan 13;7(1):e1001254. doi: 10.1371/journal.ppat.1001254.

14.

Cytokine dependent and independent iNKT cell activation.

Reilly EC, Wands JR, Brossay L.

Cytokine. 2010 Sep;51(3):227-31. doi: 10.1016/j.cyto.2010.04.016. Review.

15.

A protocol for the production of KLRG1 tetramer.

Terrizzi SC, Banh C, Brossay L.

J Vis Exp. 2010 Jan 12;(35). pii: 1701. doi: 10.3791/1701.

16.

Immunoregulatory functions of KLRG1 cadherin interactions are dependent on forward and reverse signaling.

Banh C, Fugère C, Brossay L.

Blood. 2009 Dec 17;114(26):5299-306. doi: 10.1182/blood-2009-06-228353. Epub 2009 Oct 23.

17.

A new approach for quantitative phosphoproteomic dissection of signaling pathways applied to T cell receptor activation.

Nguyen V, Cao L, Lin JT, Hung N, Ritz A, Yu K, Jianu R, Ulin SP, Raphael BJ, Laidlaw DH, Brossay L, Salomon AR.

Mol Cell Proteomics. 2009 Nov;8(11):2418-31. doi: 10.1074/mcp.M800307-MCP200. Epub 2009 Jul 14.

18.

NKT cell immune responses to viral infection.

Tessmer MS, Fatima A, Paget C, Trottein F, Brossay L.

Expert Opin Ther Targets. 2009 Feb;13(2):153-62. doi: 10.1517/14712590802653601 . Review.

19.

Invariant natural killer T cells suppress the neutrophil inflammatory response in a mouse model of cholestatic liver damage.

Wintermeyer P, Cheng CW, Gehring S, Hoffman BL, Holub M, Brossay L, Gregory SH.

Gastroenterology. 2009 Mar;136(3):1048-59. doi: 10.1053/j.gastro.2008.10.027. Epub 2008 Nov 1.

20.

Cutting edge: Priming of NK cells by IL-18.

Chaix J, Tessmer MS, Hoebe K, Fuséri N, Ryffel B, Dalod M, Alexopoulou L, Beutler B, Brossay L, Vivier E, Walzer T.

J Immunol. 2008 Aug 1;181(3):1627-31.

21.

NK cell-like behavior of Valpha14i NK T cells during MCMV infection.

Wesley JD, Tessmer MS, Chaukos D, Brossay L.

PLoS Pathog. 2008 Jul 18;4(7):e1000106. doi: 10.1371/journal.ppat.1000106.

22.

A role for interleukin-12/23 in the maturation of human natural killer and CD56+ T cells in vivo.

Guia S, Cognet C, de Beaucoudrey L, Tessmer MS, Jouanguy E, Berger C, Filipe-Santos O, Feinberg J, Camcioglu Y, Levy J, Al Jumaah S, Al-Hajjar S, Stephan JL, Fieschi C, Abel L, Brossay L, Casanova JL, Vivier E.

Blood. 2008 May 15;111(10):5008-16. doi: 10.1182/blood-2007-11-122259. Epub 2008 Mar 4.

23.

The ontogeny and fate of NK cells marked by permanent DNA rearrangements.

Pilbeam K, Basse P, Brossay L, Vujanovic N, Gerstein R, Vallejo AN, Borghesi L.

J Immunol. 2008 Feb 1;180(3):1432-41.

24.

A Y chromosome-linked factor impairs NK T development.

Wesley JD, Tessmer MS, Paget C, Trottein F, Brossay L.

J Immunol. 2007 Sep 15;179(6):3480-7.

25.

KLRG1 binds cadherins and preferentially associates with SHIP-1.

Tessmer MS, Fugere C, Stevenaert F, Naidenko OV, Chong HJ, Leclercq G, Brossay L.

Int Immunol. 2007 Apr;19(4):391-400. Epub 2007 Feb 16.

PMID:
17307799
26.

Cutting edge: IFN-gamma signaling to macrophages is required for optimal Valpha14i NK T/NK cell cross-talk.

Wesley JD, Robbins SH, Sidobre S, Kronenberg M, Terrizzi S, Brossay L.

J Immunol. 2005 Apr 1;174(7):3864-8.

27.

The mouse CD1d cytoplasmic tail mediates CD1d trafficking and antigen presentation by adaptor protein 3-dependent and -independent mechanisms.

Lawton AP, Prigozy TI, Brossay L, Pei B, Khurana A, Martin D, Zhu T, Späte K, Ozga M, Höning S, Bakke O, Kronenberg M.

J Immunol. 2005 Mar 15;174(6):3179-86.

28.

Direct effects of T-bet and MHC class I expression, but not STAT1, on peripheral NK cell maturation.

Robbins SH, Tessmer MS, Van Kaer L, Brossay L.

Eur J Immunol. 2005 Mar;35(3):757-65.

29.

Expansion and function of CD8+ T cells expressing Ly49 inhibitory receptors specific for MHC class I molecules.

Anfossi N, Robbins SH, Ugolini S, Georgel P, Hoebe K, Bouneaud C, Ronet C, Kaser A, DiCioccio CB, Tomasello E, Blumberg RS, Beutler B, Reiner SL, Alexopoulou L, Lantz O, Raulet DH, Brossay L, Vivier E.

J Immunol. 2004 Sep 15;173(6):3773-82.

30.

Expansion and contraction of the NK cell compartment in response to murine cytomegalovirus infection.

Robbins SH, Tessmer MS, Mikayama T, Brossay L.

J Immunol. 2004 Jul 1;173(1):259-66.

31.

Differential distribution of the JC virus receptor-type sialic acid in normal human tissues.

Eash S, Tavares R, Stopa EG, Robbins SH, Brossay L, Atwood WJ.

Am J Pathol. 2004 Feb;164(2):419-28.

32.

Inhibition of CD1d activation suppresses septic mortality: a role for NK-T cells in septic immune dysfunction.

Rhee RJ, Carlton S, Lomas JL, Lane C, Brossay L, Cioffi WG, Ayala A.

J Surg Res. 2003 Nov;115(1):74-81.

PMID:
14572776
33.

Differential regulation of killer cell lectin-like receptor G1 expression on T cells.

Robbins SH, Terrizzi SC, Sydora BC, Mikayama T, Brossay L.

J Immunol. 2003 Jun 15;170(12):5876-85.

34.

NK T cell-NK cell cross-talk: reciprocal interaction and activation?

Wesley J, Brossay L.

Arch Immunol Ther Exp (Warsz). 2003;51(2):121-6. Review.

PMID:
12776911
35.

Autoreactive T cells can be protected from tolerance induction through competition by flanking determinants for access to class II MHC.

Maverakis E, Beech J, Stevens DB, Ametani A, Brossay L, van den Elzen P, Mendoza R, Thai Q, Macias LH, Ethell D, Campagnoni CW, Campagnoni AT, Sette A, Sercarz EE.

Proc Natl Acad Sci U S A. 2003 Apr 29;100(9):5342-7. Epub 2003 Apr 21.

36.

NK cell receptors: emerging roles in host defense against infectious agents.

Robbins SH, Brossay L.

Microbes Infect. 2002 Dec;4(15):1523-30. Review.

PMID:
12505524
37.

Cutting edge: inhibitory functions of the killer cell lectin-like receptor G1 molecule during the activation of mouse NK cells.

Robbins SH, Nguyen KB, Takahashi N, Mikayama T, Biron CA, Brossay L.

J Immunol. 2002 Mar 15;168(6):2585-9.

38.

NK cells and NKT cells in innate defense against viral infections.

Biron CA, Brossay L.

Curr Opin Immunol. 2001 Aug;13(4):458-64. Review.

PMID:
11498302
39.

Crucial amino acid residues of mouse CD1d for glycolipid ligand presentation to V(alpha)14 NKT cells.

Kamada N, Iijima H, Kimura K, Harada M, Shimizu E, Motohashi Si, Kawano T, Shinkai H, Nakayama T, Sakai T, Brossay L, Kronenberg M, Taniguchi M.

Int Immunol. 2001 Jul;13(7):853-61.

PMID:
11431415
40.

Glycolipid antigen processing for presentation by CD1d molecules.

Prigozy TI, Naidenko O, Qasba P, Elewaut D, Brossay L, Khurana A, Natori T, Koezuka Y, Kulkarni A, Kronenberg M.

Science. 2001 Jan 26;291(5504):664-7.

41.

Structural requirements for antigen presentation by mouse CD1.

Burdin N, Brossay L, Degano M, Iijima H, Gui M, Wilson IA, Kronenberg M.

Proc Natl Acad Sci U S A. 2000 Aug 29;97(18):10156-61.

42.

Membrane lymphotoxin is required for the development of different subpopulations of NK T cells.

Elewaut D, Brossay L, Santee SM, Naidenko OV, Burdin N, De Winter H, Matsuda J, Ware CF, Cheroutre H, Kronenberg M.

J Immunol. 2000 Jul 15;165(2):671-9.

43.

Highly conserved antigen-presenting function of CD1d molecules.

Brossay L, Kronenberg M.

Immunogenetics. 1999 Nov;50(3-4):146-51. Review.

PMID:
10602876
44.

Conserved lipid and peptide presentation functions of nonclassical class I molecules.

Kronenberg M, Brossay L, Kurepa Z, Forman J.

Immunol Today. 1999 Nov;20(11):515-21. No abstract available.

PMID:
10529780
45.
46.
48.

Diverse CD1d-restricted reactivity patterns of human T cells bearing "invariant" AV24BV11 TCR.

Couedel C, Peyrat MA, Brossay L, Koezuka Y, Porcelli SA, Davodeau F, Bonneville M.

Eur J Immunol. 1998 Dec;28(12):4391-7.

49.

Presentation of peptide antigens by mouse CD1 requires endosomal localization and protein antigen processing.

Tangri S, Brossay L, Burdin N, Lee DJ, Corr M, Kronenberg M.

Proc Natl Acad Sci U S A. 1998 Nov 24;95(24):14314-9.

50.

Structural requirements for galactosylceramide recognition by CD1-restricted NK T cells.

Brossay L, Naidenko O, Burdin N, Matsuda J, Sakai T, Kronenberg M.

J Immunol. 1998 Nov 15;161(10):5124-8.

Supplemental Content

Loading ...
Support Center